Symbol="EDIT"
AssetType="Common Stock"
Name="Editas Medicine Inc"
Description="Editas Medicine, Inc., a clinical-stage genome editing company, is focused on developing transformative genomic drugs to treat a variety of serious diseases. The company is headquartered in Cambridge, Massachusetts."
CIK="1650664"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="BIOLOGICAL PRODUCTS, (NO DISGNOSTIC SUBSTANCES)"
Address="11 HURLEY ST., CAMBRIDGE, MA, US"
FiscalYearEnd="December"
LatestQuarter="2023-03-31"
MarketCapitalization="713334000"
EBITDA="-219838000"
PERatio="None"
PEGRatio="0"
BookValue="4.738"
DividendPerShare="0"
DividendYield="0"
EPS="-3.08"
RevenuePerShareTTM="0.331"
ProfitMargin="0"
OperatingMarginTTM="-9.92"
ReturnOnAssetsTTM="-0.26"
ReturnOnEquityTTM="-0.527"
RevenueTTM="22792000"
GrossProfitTTM="-155246000"
DilutedEPSTTM="-3.08"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="0.455"
AnalystTargetPrice="13.41"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="26.38"
PriceToBookRatio="1.718"
EVToRevenue="12.25"
EVToEBITDA="-1.587"
Beta="1.801"
num_52WeekHigh="19.97"
num_52WeekLow="6.33"
num_50DayMovingAverage="9.03"
num_200DayMovingAverage="9.38"
SharesOutstanding="81526000"
DividendDate="None"
ExDividendDate="None"
symbol="EDIT"
open="8.68"
high="8.76"
low="8.56"
price="8.67"
volume="1282959.00"
latest_trading_day="2023-07-28"
previous_close="8.50"
change="0.17"
change_percent="2.0000%"
aroon_positive_momentum_days="59"
aroon_negative_momentum_days="0"
trend_strength="Absent or Weak Trend"
buying_signal="Weak Buy Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="59"
Volume_recent_avg="2004943"
Change_recent_avg="0.01"
Delta_recent_avg="0.54"
Variance_recent_avg="0.27"
Change_ratio_recent_avg="-0.17"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="positive"
Aroon_change="FALSE"
Aroon_momentum_positive="59"
Aroon_momentum_negative="41"
image_negative_thumbnail_id_1="1137"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0170.jpeg"
image_negative_thumbnail_id_2="1110"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0143.jpeg"
image_neutral_thumbnail_id_1="540"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0059.jpeg"
image_neutral_thumbnail_id_2="583"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0016.jpeg"
image_positive_thumbnail_id_1="642"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0066.jpeg"
image_positive_thumbnail_id_2="626"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0082.jpeg"
image_professor_thumbnail_id_1="1186"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0020.jpeg"
image_professor_thumbnail_id_2="1199"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0033.jpeg"
